Clinical Trial

Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer

Study acronym: FIBROTHERME
Recruiting
View on ClinicalTrials.gov →
Summary
FIBROTHERME is a comparative, controlled, randomized, multicenter and simple blinded (investigator) trial. The aim of this study is to evaluate the medical benefit in terms of quality of life on the dermatological sequelae of fibrosis 6 months after a dermatologically oriented spa therapy in patients with severe late reactions affecting the skin and/or soft tissues at least 6 months after radiotherapy for breast cancer or UADT (Upper Aerodigestive Tract) cancer.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-05-15; most recent amendment 2026-04-08.
Status change: Not Yet Recruiting → Recruiting 2024-03-05
Trial Details
NCT Number NCT05874492
Lead Sponsor Association Francaise pour la Recherche Thermale
Collaborators: Floralis
Conditions Fibrosis, Breast Cancer, Head and Neck Cancer
Enrollment 110 participants
Start Date 2024-01-29
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-13